Dementia and Alzheimer Disease

Epilepsy

Migraine

Headache and Migraine

MS Advanced Practice Providers

Multiple Sclerosis

NMOSD

MS and Demyelinating Disorders

Parkinson Disease

Movement Disorders

Ataxia

Chronic Inflammatory Demyelinating Polyneuropathy

Muscular Dystrophy

Neuromuscular

Insomnia

Narcolepsy

Sleep Disorders

Stroke

News

Media

All Videos

Medical World News

Podcasts

Weekly Recap

Cure Connections

Insights

News Network

NeurologyLive Peer Exchange

Medcast Podcasts

Medcast Videos

Peers & Perspectives

Roundtable Discussions

Conferences

Conference Coverage

Conference Listing

CME/CE

Partners

Publications

NeurologyLive

Bridging the Gaps

International Journal of MS Care

Resources

Disease Spotlight

Fellows' Corner

Future Leaders in Neurology

Giants of Multiple Sclerosis

Interactive Tools

Live Events

Neurology Resources

Virtual Events

Subscribe

Articles

Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on Huntington disease.

NeurologyLive® Brain Games: May 19, 2024

Sean Pittock, MD, director for the Mayo Clinic Center for Multiple Sclerosis and Autoimmune Neurology detailed interim data from the open-label extension of the pivotal CHAMPION-NMOSD trial, the study that led to ravulizumab’s approval. 

Reviewing Ravulizumab’s Long-Term Profile as New NMOSD Treatment

ION541, an antisense oligonucleotide, failed to demonstrate impact on outcomes of function, breathing, and strength, in addition to no impact on neurofilament light.

Biogen, Ionis Terminate BIIB105 Following Disappointing Phase 1/2 Results

Videos

Neurology News Network. for the week ending May 18, 2024. [WATCH TIME: 4 minutes]

Dosing Commenced in Study of Anti-Tau Agent, FDA Updates Labeling to Glatiramer Acetate Products, Eisai Initiates Rolling Submission for Subcutaneous Lecanemab 

The associate professor of neurology at Harvard Medical School talked about findings from a recent case series of patients with NMOSD initially on rituximab who then switched to inebilizumab. [WATCH TIME: 4 minutes]

Efficacy of Switching From to Inebilizumab in Rituximab in NMOSD: Michael Levy, MD, PhD

, has been with the team since October 2019. Follow him on Twitter 

Mayo's MOGAD Clinic represents a new type of novel, multidisciplinary care, incorporating multiple different backgrounds of neurology, neuroimmunology, neuro—ophthalmology, and urology, among others.

Building the Archetype for MOGAD Care: Introducing Mayo’s New Clinic

The Consortium of Multiple Sclerosis Centers' 38th Annual Meeting will be held Wednesday, May 29, through Saturday, June 1, 2024 at the Music City Center, in Nashville, Tennessee.

CMSC 2024: What to Expect From This Year's Annual Meeting

Cure SMA introduces tools aiding in SMA clinical trial navigation and participation empowerment.

Cure SMA Unveils Initiatives to Improve Clinical Trial Accessibility

NeurologyLive is your direct connection to the latest neurology news and interviews with expert neurologists in multimedia formats.

About Us

Advisory Board

Editorial

Contact Us

Advertise

Contact MJH LS

Do Not Sell My Information

Terms and Conditions

Privacy

NeurologyLive – Clinical Neurology News and Neurology Expert Insights

Facebook

Twitter

LinkedIN

YouTube

Spotlight

AAN 2024

MDA 2024

ACTRIMS 2024

Treating NMOSD: What's Next?

Clinical Focus

Dementia/Alzheimer

Headache/Migraine

Video Series

1rem

View

Insomnia and Sleep Disorders in Primary Care Settings

Paul Doghramji, MD, FAAFP, provides insight on the use of current treatment modalities for insomnia and the management of sleep disorders in primary care clinics.

Paul Doghramji, MD, FAAFP, provides an overview of the prevalence of sleep disorders, including insomnia, in the primary care setting.

Prevalence of Sleep Disorders in Primary Care Clinics

Dr Paul Doghramji shares insight on reasons for the underdiagnosis of insomnia and the importance of treating sleep disorders concurrently with comorbidities.

Identification of Sleep Disorders in Primary Care Clinics

An expert in sleep medicine comments on approaching screening patients for insomnia or other sleep disorders in the primary care setting.

Screening for Sleep Disorders in Primary Care Clinics

Paul Doghramji, MD, FAAFP, discusses best practices for referring patients with sleep issues to a sleep specialist.

Patient Referrals for Sleep Disorder Management

Dr Paul Doghramji shares tips for communication with patients once an insomnia diagnosis has been made.

Approaching Patient Conversations for Sleep Disorder Management

An expert in sleep medicine provides insight on the use of traditional insomnia medications in patients as well as DORAs, and common challenges experienced with these treatment options.

Treatment Options for Insomnia

Paul Doghramji, MD, FAAFP, shares his personal experience with DORAs in clinical practice to manage insomnia and discusses treatment adherence with insomnia medications.

Using DORAs for the Treatment of Insomnia

Dr Paul Doghramji shares his approach to switching medications for the treatment of insomnia.

Treatment Adherence and Switching Treatments for Insomnia

An expert in sleep medicine highlights challenges in prescribing DORAs and importance of discussing insomnia with patients in the primary care setting.

Access and Treatment of Insomnia in Primary Care Clinics

Clinical

Lasso - DMD Peers and Perspectives NSP-21-NRD0157

 video series brings together pairs of expert clinicians and physicians to independently provide their insights on the latest and most up-to-date clinical care for specific neurologic diseases and disorders.

Prevalence of Sleep Disorders in Primary Care Clinics

EP: 1.Prevalence of Sleep Disorders in Primary Care Clinics

EP: 2.Identification of Sleep Disorders in Primary Care Clinics

EP: 3.Screening for Sleep Disorders in Primary Care Clinics

EP: 4.Patient Referrals for Sleep Disorder Management

EP: 5.Approaching Patient Conversations for Sleep Disorder Management

EP: 6.Treatment Options for Insomnia

EP: 7.Using DORAs for the Treatment of Insomnia

EP: 8.Treatment Adherence and Switching Treatments for Insomnia

EP: 9.Access and Treatment of Insomnia in Primary Care Clinics